Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03684785
Brief Title: Intratumoral Cavrotolimod Combined With Pembrolizumab or Cemiplimab in Patients With Merkel Cell Carcinoma, Cutaneous Squamous Cell Carcinoma, or Other Advanced Solid Tumors

First Submitted : September 19, 2018
First Submitted that Met QC Criteria : September 24, 2018
First Posted : September 26, 2018

Last Update Submitted that Met QC Criteria : January 11, 2021
Last Update Posted : January 12, 2021